
Clients
Assignments
Years Global Experience
US$ 500+ MM X-Border deals and Investments
We are eager to contribute to your Success, please let us know your needs for a preliminary evaluation at no cost.
Aagami has been awarded a new mandate by its French biotech client to support the out-licensing of NFL-101, the client’s lead Phase 3 asset for smok...
Read MoreAagami, Inc., a boutique global life science strategic consulting firm, has been awarded an exclusive, unrestricted global advisory assignment by a pr...
Read MoreAagami is pleased to announce a new strategic client win with a pioneering France-headquartered pharmaceutical company. Under this newly signed mandat...
Read More